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Viability of diagnostic decision support for  
antenatal care in rural settings: findings from the 
Bliss4Midwives Intervention in Northern Ghana
Background Antenatal screening is useful for early identification and manage-
ment of high-risk pregnancies. In low-resource settings, provision of the full 
complement of tests is limited and diagnostic referrals incure additional costs 
for pregnant women. We assessed the viability of Bliss4Midwives (B4M) - a 
point-of-care diagnostic decision support device for decentralized screening of 
pre-eclampsia, gestational diabetes and anaemia during antenatal care (ANC).
Methods The device was piloted in seven health facilities across two districts 
in Northern Ghana over a ten-month period. Health workers were expected 
to screen women at each ANC visit till delivery. All screening records from 
the device were automatically archived digitally and later downloaded. After 
removing duplicates or invalid entries, descriptive quantitative analysis was 
carried out with IBM SPSS Statistics (version 23). B4M usage behavior, diag-
nostic and referral outcome were analyzed.
Results Health workers conducted 1323 partial or full antenatal screening 
on 940 women, resulting in decision support for 835 (88.8%) B4M benefi-
ciaries. Diagnostic referral was eliminated for 708 (84.7%) beneficiaries, with 
335 (40.1%) of these from facilities without on-site diagnostic alternatives. 
Of visits with complete data, 92/559 (16.4%) women were screened in their 
first trimester, 28/940 (2.9%) had 4+ B4M visits and 107/835 (12.8%) wom-
en were recommended for urgent referral to a higher-level facility on the first 
visit. Follow-up screenings flagged an additional 17 women for urgent referral 
with 10 cases of repeated alerts in five women. Wide variations between high 
(9 months use) and low adopting (1.5 months use) facilities were observed, 
with some similarities in usage trend.
Conclusions B4M helped decentralize ANC screening and decrease unnec-
essary referrals. Project outcomes were influenced by implementation strate-




Alongside counselling during antenatal care (ANC), screening for anaemia, hyper-
glycemia and sexually transmitted infections, amongst others, is important for the 
management of pregnancy-related complications [1,2]. In rural settings, laborato-
ries may be unavailable or ill equipped such that pregnant women cannot receive 
the full complement of screening at the point-of-care (POC). They are therefore 
subject to diagnostic referral and may have to travel long distances, which is a bar-
rier to accessing the optimal package of maternal health services [3]. Additionally, 
front-line workers are not always trained or equipped to properly conduct ANC 
screening. Other factors that contribute to diagnostic gaps at peripheral levels in-
clude staff shortages, geographic isolation and cost implications [4]. These pose a 
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challenge for ensuring early identification and timely decision-making on the management of conditions 
that could endanger the health of mother and child [5].
In Ghana, up to 35% of pregnant women were anaemic (haemoglobin <11g/dl) at their first ANC visit, 
with severe anaemia and malaria accounting for 26% of maternal mortality [6]. Independent cross-section-
al studies in a Ghanaian tertiary hospital indicate about 10% prevalence of gestational diabetes and 7.5% 
of pre-eclampsia in pregnant women [7,8]. Although ANC coverage has generally improved in Ghana, 
and over 80% of pregnant women had at least one contact with a skilled health provider in 2016, recent 
data shows disparities between its 10 regions (100% ANC coverage in the Northern region (NR) but only 
70% in the Volta region) [6]. Evidence also indicates that the recommend number and timing of visits 
are not being achieved. Nationally, 76% of women attend at least four visits and less than 50% initiate 
ANC within the first trimester, with rural women being less likely to engage with the formal health sec-
tor [6,9]. Only 83% of women in rural areas have 4+ ANC visits compared to urban women (92%) [10]. 
In the Northern and Upper East regions- two regions with the highest poverty levels, 4+ ANC visits were 
73% and 93% respectively [10,11]. While efforts have been made to ensure that women in remote areas 
can access maternal and child services, not all health facilities have the capacity for diagnostic screening. 
Women thus have to travel to alternative sites for basic tests, increasing the financial burden for transport 
and service charges. Poor feedback between facilities results in low referral compliance, affecting patient 
monitoring and accurate record keeping [6]. To ensure access to quality care for all pregnant women, 
there is a need for alternative strategies that consider contextual limitations.
Point-of-care and decision support technologies are reported to improve service delivery and aid task 
shifting, bridge the know-do gap and empower workers to take clinical decisions [12-14]. In June 2016, 
a consortium of five Dutch organizations and two Ghanaian partners launched an integrated diagnostic 
and decision support device in two districts of Northern Ghana. The one-year proof-of-concept tagged 
Bliss4Midwives (B4M) aimed to reduce pregnancy-related complications by improving quality antenatal 
care (ANC) through non-invasive diagnostic tests supported by decision algorithms. By facilitating POC 
screening for pre-eclampsia, gestational diabetes and anaemia, the intervention was expected to facilitate 
early detection, woman-friendly consultation and streamlined referral pathways.
To assess its viability, the pilot project was evaluated. We present an overview of the intervention alongside 
findings on usage behaviour and referral recommendations. Analysis focused on how each health facility 
performed with using B4M. Only records of women who were screened with the device were analyzed, 
regardless of the total number of women that attended ANC visits during the project period. Pregnant 




Seven prototype B4M devices were assembled (Figure 1). Each device is composed of three diagnostic 
and two supportive components.
B4M diagnostic components
•  Non-invasive Pronto-7® Rainbow Pulse CO-Oximetry™ device (Masimo Corporation, Irvine, 
California, USA) for arterial oxygen haemoglobin, pulse rate and total haemoglobin concentra-
tion. Signals are transmitted from the woman to the device through infrared sensors mounted on 
a finger clip.
•  Suntech Medical® Advantage™ OEM non-invasive blood pressure (OEM-NIBP) device with au-
tomated arm cuff (Suntech Med Inc, Morrisville, NC, USA).
•  Urisys 1100® Urine Analyzer (Roche Diagnostics, Risch-Rotkreuz, Switzerland), which automat-
ically reads protein and glucose levels in urine through Chemstrip®. It operates on the principle 
of reflectance photometry, eliminating the need for visual interpretation of results, which is prone 
to error.
Diagnostic components meet requirements of the Food and Drug Administration or European Standard 
of Electronic Engineering and conform to standards for developing medical prototypes- ISO 13485 [16].
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•  An android tablet that paired with diagnostic components via Bluetooth was pre-programmed with 
decision support algorithms according to Ghana Health Service guidelines. The decision support 
component used a traffic-light system to indicate level of risk or referral urgency while prompting 
patient counseling, management or referral. Textual recommendations accompanied visual indi-
cators on whether hospital referral was needed. Where necessary, immediate actions to take were 
indicated. Screening records were saved without Internet access and program managers regularly 
exported the data to an external device.
•  Pregnant women were linked to the system on the first B4M screening visit via Quick Response 
(QR) codes affixed to their health record booklets. This allowed quick and easy recall of records 
on subsequent visits.
Diagnostic data were automatically or manually (only hemoglobin) uploaded to the tablet. In addition 
to updating clinical history and hemoglobin (Hb) results manually, B4M users were expected to input 
delivery date and outcome as well as summarized notes on their observations or actions. Devices could 
be locked and transported between locations. Except for the haemoglobinometer that used disposable 
batteries, a rechargeable lithium battery powered all prototype components. When fully charged, com-
ponents could operate without electricity for up to seven hours. Consumables (Chemstrip®, disposable 
batteries, finger sensors) were replenished by the project on request. Other technical details of the device 
are beyond the scope of this paper.
Implementation setting and process
The device was implemented in the Upper East Region (UER) and Northern Region (NR) of Ghana. All 
intervention sites are predominantly rural and about half of the population is illiterate [17-19]. Five health 
facilities per region were enrolled, but technical and implementation challenges such as defective devices 
and transfer of trained staff reduced the total number to seven- four health facilities (facilities A-D) from 
UER and three facilities (facilities E-G) from NR. Because it was a pilot, B4M was used in addition to the 
pre-existing paper-based ANC routine and health workers were expected to screen all women who came 
for ANC at each visit till delivery.
Three devices were situated in each region and one device reserved for backup. Facility selection was large-
ly guided by high ANC-load per facility, remote distance from referral hospital and possibility that more 
women would benefit from the device. Devices were assigned to facilities on a fixed or rotational basis. 
Higher caseload facilities such as hospitals had a fixed device. Where a facility was too remote for conve-
nient rotation (eg, facility G), it had a fixed device. Each B4M visit ideally involved a systematic step-wise 
process starting with enrolment of first time beneficiaries using their data and history, followed by pre-
senting complaints, diagnostic screening and referral decision. Client counselling concluded each visit. 
Based on pre-intervention estimates, 100 pregnant women per health facility were expected to be screened 
in a year, with 40 women completing at least four ANC visits between early pregnancy and delivery [16].
Twenty-five midwives and community health workers received two-days training on B4M. This includ-
ed refresher training on managing pregnancy complications and principles of quality ANC. Three field 
personnel with technical backgrounds, and two program officers (one in each region) were also trained 
to provide technical support.
Figure 1. B4M device. 1 – Portable water and 
heat resistant dustproof case; 2 – Automated 
blood pressure cuff; 3 – Urinary glucose and 
protein Chemistrips; 4 – Urisys 1100® Urine 
Analyzer; 5 – Pronto-7® Rainbow Pulse 
CO-Oximetry device; 6 – Android tablet with 
decision support algorithms; 7 – Traffic-sig-
naling alert system; 8 – Unique QR code for 
easy tracking and recall of patient records; 9 
– AC adapter for charging the device.
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Data collection and analysis
The Android tablet was programmed to automatically archive all screening records and usage informa-
tion in a downloadable repository. Such information included: kit number, B4M visit date, B4M visit 
number and QR code, mother’s name, parity, expected date of delivery, gestational age, delivery date and 
outcome of delivery, patient history, presenting complaints, diagnostic decisions, action (ie, counseling, 
testing and treatment) and referral recommendations. The study sample was limited to all women who 
were screened with the device; therefore excluding those who attended ANC visits during the project pe-
riod without being screened with B4M. A member of the project team downloaded the repository from 
each device. Records were de-identified, cleaned and sorted for duplicates or invalid entries (eg, records 
from training or trial sessions) using Excel. Descriptive quantitative analysis of records archived over a 
10-month period (15th June 2016 to 18th April 2017) was carried out using IBM SPSS Statistics (version 
23) (IBM Inc, Armonk, NY, USA).
Ethical considerations
Navrongo Health Research Centre Institutional Review Board (Approval ID: NHRCIRB18) and EMGO+ 
Scientific Committee of the Amsterdam Public Health Institute (Reference Number: WC2017-026), grant-
ed study approval. Most information collected in the B4M repository represented data that should also 
be recorded in the paper-based maternal health record books at each facility. This includes the name, ad-
dress, parity, age and gestational age of women. Because record books are not necessarily stored securely, 
they pose a higher privacy risk as anyone could easily access information on ANC attendees. To ensure 
data protection and privacy, the personal data of women were linked through the anonymised QR code, 
each with a unique alphanumeric project label (see Figure 1, item 8). Furthermore, each B4M user was 
assigned a username and password and only personnel with access could assign or scan QR codes, view 
personal and clinical data and conduct the tests with the device. Prior to assigning QR codes to ANC at-
tendees at their first B4M screening, health workers were trained to enrol pregnant women into the study 
using a structured information sheet that explained the study procedure, benefits, risks and confidenti-
ality. Women confirmed consent with a signature or thumbprint. The device was introduced as an addi-
tional station in the existing ANC workflow and could be locked and securely stored when not in use.
RESULTS
Beneficiary characteristics and B4M service delivery
In the seven intervention facilities, 1323 antenatal screenings were conducted in 940 women. With an 
average of three and a maximum of ten pregnancies per woman, 283 (30%) B4M beneficiaries were pri-
migravidae (first pregnancy) and 78 (8%) were grand multiparous (>5 pregnancies). Up to 12% of ben-
eficiaries represented high-risk age groups for pregnancy- 51 (5.4%) women were less than 18 years old, 
while 64 (6.8%) women were older than 35 years.
Actual device adoption over a ten-month period differed between regions and facilities, ranging from 1.5 
to 9 months. Length of actual use was calculated as the duration between the first and last B4M screening 
record at each facility (Table 1). Health facilities in UER demonstrated higher usage behavior- account-
ing for 950 (71.8%) screening records and 646 (68.7%) beneficiaries. In the NR, 373 (28.1%) screening 
records represented B4M visits for 294 (31.2%) women.
Compliance to B4M
Due to missing values, it was only possible to calculate first B4M visit as a function of gestational age for 
559 (59%) women (Figure 2). Of these, the number of women screened with B4M in their first trimes-
ter (<13weeks) was rather low – 92 (16.4%). Interestingly, a large number – 268 (47.9%) women were 
screened for the first time after 24 weeks gestation.
Usage trend over the project period was plotted to understand critical points of use or non-use of B4M. 
An unexpected wavelike pattern starting with a steady increase in number of screenings was found in all 
health facilities (Figure 3, phase I). Between August and October 2016 (phase II), number of records fell 
despite expectations that enrolled women will be re-assessed in repeat ANC visits, with new registrants 
supplementing these numbers. Facility A showed the widest decline at this stage, and did not use the 
device between December 2016 and January 2017 (phase IV). Despite phase IV cessation of B4M use in 
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facility A and declined use in facility D, both sites manifested usage surge by February 2017 (phase V). 
With a slight exception in facility B, no facility reattained initial peak usage rates.
Irrespective of differences in facility type and implementation strategy, health facilities (more specifically 
A, B and D) seemed to follow a similar wave pattern from phases I through VI, with usage increasing and 
declining within the same time period.
Of the 940 B4M beneficiaries, 28 (2.9%) received four or more screening visits. Although facilities A, 
D and F served about the same number of pregnant women, only facility D had the highest number of 
follow-up B4M screenings per woman- up to 8 (0.8%) women had 5+ B4M screening visits (Figure 4).
Information requiring manual entry was often not entered or had errors due to oversight on the part of 
users. Once detected, the monitoring team attempted to address this by encouraging users to pay atten-
tion to accuracy and completeness of entries. Nevertheless, manual feedback notes on health workers’ 
actions were entered in only half of the visits. Delivery outcome was entered in only 30 cases, although 
536 women were due for delivery within the project timeline.
Table 1. B4M service delivery
HealtH Facility* type oF HealtH 
Facility† Fixed or rotating device
lengtH oF use 
(montHs)
screening records 
n = 1323 (100%)
Women screened 
n = 940 (100%)
Upper East Region:
Facility A Secondary Fixed 9 284 (21.5%) 252 (26.8%)
Facility B Primary Rotating (with facility C) 6 69 (5.2%) 63 (6.7%)
Facility C Primary Rotating (with facility B) 3.5 129 (9.8%) 78 (8.3%)
Facility D Primary Fixed 9 468 (35.4%) 253 (26.9%)
Northern Region:
Facility E Primary Fixed 1.5 25 (1.9%) 25 (2.7%)
Facility F Primary Fixed 1.5‡ 337 (25.5%) 258 (27.4%)
Facility G Primary Fixed 1.5 11 (0.8%) 11 (1.2%)
*Facility A is the ANC unit of a district hospital, which is the first level referral point for facilities B, C and D, which are health cen-
ters. Facility E is an independent public health unit of a district hospital, while F and G are health centers.
†Differentiated by level of service provision: primary facilities provide basic community-level services while secondary facilities are 
usually district hospitals with capacity for more specialized care.
‡Dating errors in 302 records.
Figure 2. Gestational age at first B4M visit. Figure 3. Trend analysis of B4M usage.
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Unlike other test results, which were automatically up-
loaded to the Android tablet, Haemoglobin (Hb) re-
sults had to be entered manually by health workers. 
Of 1323 screening visits, 34 (2.5%) Hb measurements 
had typing errors (eg, missing the decimal point) and 
78 (5.8%) did not include Hb data, leaving 1211 
(91.5%) valid records. Mean Hb reading was 12.5 g/
dl (SD = 1.3) with median 12.6 g/dl and range from 
5.0 to 16.6 g/dl. Of valid records, 114 (9.4%) were 
between 7 and 11 g/dl, prompting recommendation 
of a 2-week follow-up visit and a reminder to give iron 
tablets and counsel on adequate pregnancy nutrition. 
Only one woman had Hb <7 g/dl, mandating urgent 
referral (Figure 5).
Blood pressure
B4M screening records from 1287 (97.4%) visits in-
cluded blood pressure (BP) measurements. Mean sys-
tolic pressure was 104.24 mm Hg (SD = 13.6) and 
mean diastolic 65 mm Hg (SD = 10.1), with median 
102 mm Hg (range 67 to 191 mm Hg) and 64 mm 
Hg (range from 40 to 149 mm Hg), respectively (Fig-
ure 6).
Urinalysis (protein and glucose)
In 1315 (99.4%) of B4M-ANC visits, urinalysis had 
been conducted. In 115 (8.7%) of completed tests, an 
increased urine glucose (≥100 mg/dL) was identified, 
and in four instances, levels were >1000 mg/dl. Health 
workers were advised to refer women, based on in-
creased urinary glucose following 28 visits. Scheduling 
a two-week follow-up screening was recommended in 
83 instances. Urinary protein was elevated (≥30 mg/
dL) in 164 (12.5%) samples. In eight cases, levels were 
as high as 500 mg/dl and workers were prompted to 
follow-up with testing for urinary tract infections. Re-
sults from blood pressure and urinalysis were collec-
tively factored into the decision algorithm for action 
on pre-eclampsia; nine women were flagged for urgent 
referral and 117 women for close monitoring (ie, two-
week follow-up).
Figure 4. Compliance to repeat screening.
Figure 5. Screening for anaemia.
Decision support and referral advice
Combined analysis of the different diagnostic tests, woman’s history, presenting complaints and expect-
ed date of delivery guided B4M referral advice. We excluded 126 (10%) records with incomplete data 
on blood pressure, urinalysis or Hb, leaving 1197 (90%) screening records representing 835 women. If 
the recommendation was “no urgency” or “attention needed” health workers scheduled women for the 
next ANC visit in four or two weeks respectively. In decisions marked “urgent referral” or “direct action 
+ urgent referral” (Table 2), women were expected to be referred to the next level of care immediately. 
Where the B4M decision was “referral recommended”, health workers were expected to decide a course 
of action using their clinical judgement and experience.
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Decision outcome for 107 (12.8%) of women with complete screening data at their first B4M visit was 
‘urgent referral’ to a higher-level facility (Figure 7). In other cases, referral urgency was detected during 
follow-up visits, representing newly detected danger signs for 17 women (15 on the 2nd visit and two at 
the 3rd) and 10 instances (5 women) of repeat referral recommendation from a previous visit.
At the time of data collection, Facilities A and F both had functional laboratories where urinalysis and 
Hb testing could be done, while Facility E regularly used POC tests acquired through a different project. 
In other facilities, B4M was the primary “mobile laboratory”, in the absence of which diagnostic referral 
was common. Table 2 shows that 708 (84.7%) women who received a B4M decision had no referral ur-
gency (“no urgency” + “attention needed”). Of these, 335 (40%) women were tested in facilities without 
on-site diagnostic alternatives.
DISCUSSION
By providing integrated diagnostic services at the point-of-care to almost 1000 women, the Bliss4Midwives 
pilot demonstrated the extent to which technology-driven alternatives for early detection and referral of 
selected conditions of pregnancy in rural settings are feasible. Even in the presence of alternatives, both 
primary and secondary facilities used the device, albeit to varying extents. Alongside individual, organisa-
tional and contextual factors, use of B4M can be linked to perceptions of its usefulness [20]. However, the 
Table 2. Distribution of B4M referral advice
no urgency attention needed reFerral recommended urgent reFerral direct action + urgent 
reFerral
Facility A 134 women 72 women 4 women 40 women –
Facility B 17 women 38 women 3 women 1 woman –
Facility C 35 women 19 women 1 woman 22 women –
Facility D 143 women 74 women 1 woman 34 women –
Facility E 9 women 6 women 2 women 5 women 1 woman
Facility F 113 women 39 women 9 women 3 women –
Facility G 5 women 4 women - 1 woman –
N = 835 (100%) 456 women (54.6%) 252 women (30.1%) 20 women (2.3%) 106 women (12.6%) 1 woman (0.1%)
Figure 6. Blood pressure screening.
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creation of parallel workflows that strain workers and lead to 
adoption resistance could have influenced users compliance 
to the device [12,21,22]. Because service providers require 
interventions to be sensitive to their context and easily inte-
grate into workflow [23,24], mobile Health (mHealth) usage 
can be low despite high perceived usefulness [25]. In light of 
contextual limitations such as high caseload and low staffing, 
and because using the device took longer, not all ANC attend-
ees were screened with B4M [15]. Some health workers did 
not use all three screening components per visit, resulting in 
partial screening.
We found wide variations between high adopting and low 
adopting facilities with some pattern similarities. Higher us-
age behavior in the UER was partly explained by technical 
issues in the NR. The device in facility G was withdrawn af-
ter three months due to charging problems. In facilities with 
a fixed device, however, consistent access did not translate 
into consistent use. Facility E had the lowest usage behav-
ior despite presence of a functioning device for about seven 
months, confirming that access alone is not sufficient to en-
sure mHealth compliance [26]. Availability of an alternative 
POC device in Facility E did not fully explain its low usage. 
Unavailability of transport, poor intervention ownership and 
limited on-site supervision influenced successful device ro-
tation between facilities B and C. Temporary absence of users, lack of electricity, technical failure, poor 
supervision and poor technical skills, are commonly reported barriers to implementing diagnostic and 
decision support systems and may also explain dips in our trend analysis [12,24]. Chaiyachati et al. not-
ed that proper training and continuous technical support did not mitigate low compliance in their study, 
suggesting the influence of broader multifaceted factors [25].
Consistent with rapidly rising usage in the early weeks of technology introduction in other studies, we 
observed the “novelty effect” [27]. However, this was not sustained and may explain why initial rates were 
not maintained. Usage levels could be systematically sustained by applying user-centred designs, iterative 
feedback processes and ensuring workflow integration [28]. B4M use in facilities A, B and D spiked in 
phase V after a preceding dip, coinciding with the period when users were informed of intentions to eval-
uate the project. This manifestation of the Hawthorne effect- people acting as expected when conscious 
of being observed [29], emphasizes the importance of supervision and monitoring in sustaining mHealth 
compliance. In order to be effective, supervision must go beyond a checklist approach. A study in North-
ern Ghana found that health workers only respond positively to supportive supervision [30]. Frimpong 
et al. add that timing, duration and frequency of monitoring should be taken into account when leverag-
ing the influence of supervision [30].
Women did not undergo their first B4M screening in early pregnancy with continuation till delivery as 
was expected and more women commenced B4M monitoring in their second and third trimesters. We 
do not exclude inaccuracies in the estimation of gestational age in explaining this result as health workers 
sometimes guess Figures [31]. Coverage of 4+ ANC visits with B4M was about 3%, although aggregate 
data from the three intervention districts show that the percentage of women attending up to four ANC 
visits is at least 50% [6]. This is likely due to known sociocultural and financial factors which posed a 
challenge to early monitoring and follow-up with the device [32,33]. Qualitative data from the project 
confirm that health workers did not systematically use the device, therefore a first B4M visit may actually 
be a woman’s third or fourth ANC visit [15].
Viability of POC tests have been widely debated along the lines of cost-effectiveness, accuracy and clinical 
effects, specifically with low-resource settings in mind [34]. Direct and indirect costs associated with ANC 
attendance are reported barriers to early and sustained visits [35,36]. Even in facilities with laboratories, 
stock-outs, high costs and long waiting times are barriers to routine antenatal screening [4]. Despite in-
consistent use, we anticipate that by eliminating the need for diagnostic referral for basic tests in at least 
335 women, decentralised screening helped save money and time. Beneficiaries report that B4M saved 
time and money, with higher perception of time efficiency in larger facilities [15]. We therefore expect that 
Figure 7. B4M referral advice per beneficiary.
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women with no indications for referral urgency, who attended ANC in facilities with on-site capabilities, 
may have benefitted from reduced waiting time due to expanded diagnostic options.
The effectiveness of POC testing has been rightly identified as being only as good as the resulting action 
[37] but we were unable to ascertain if B4M users accepted and acted on the decision recommendations. 
B4M referral warnings were sometimes repeat recommendations, suggesting that health workers did not 
adhere to referral recommendations or women did not comply. Detection of risk factors in B4M follow-up 
visits also emphasises the importance of repeat screening. Although beyond the scope of this paper, it is 
worth mentioning that implicit trust in the accuracy of diagnostic components extends to the resultant 
decision support recommendation. Congruence between referral decision and diagnostic test for hae-
moglobin was better with higher Hb values, while BP screening gave some extremely low or high values 
(Figures 5 and 6). The role that analytical or user-dependent errors played in explaining these is uncer-
tain. Nevertheless, the importance of diagnostic validity, technology design and user training already put 
forward by other researchers requires emphasis [24,26,38]. Caution must be added that B4M diagnostic 
tests were more conclusive for hypertension and glycosuria than hypertension-in-pregnancy and gesta-
tional diabetes respectively, for which additional criteria and tests are mandated.
Overall, the benefits of POC diagnostic and decision support strategies outweigh their limitations 
[12,24,26]. Continuous training, integration of results with existing health information systems and sup-
portive on-site supervision to ensure correct technique are useful strategies to sustain adoption and usage 
behavior of mHealth [24,25,37]. Going forward, modifications to the B4M prototype can reduce invalid 
data and time needed to complete a visit by automating more functions and enabling prompts that flag 
invalid or missing data. Data synchronization in a secure cloud database can allow instantaneous dash-
board analytics, giving immediate feedback to users. By functioning as an invisible eye, active electronic 
monitoring may simulate the Hawthorne effect indirectly [39]. Although the financial trade-off for in-
corporating and maintaining solar panels into the device was not feasible under the evaluated prototype, 
an alternative power source is necessary to reduce reliance on electricity and allow device use for com-
munity outreach visits. Lessons learnt from the B4M experience are applicable to similar interventions 
in other health domains. For example, the prototype can be contextually adapted to support integrated 
measurement and monitoring of diseases such as HIV, malaria and tuberculosis, as demonstrated by an 
on-going study in Nigeria [13].
Limitations
Our analysis was limited by unavailable data due to entry errors and partial screening visits. About 20% 
of all B4M records had dating errors for visit date or expected date of delivery. The majority of these were 
from facility F after a glitch resulted in incorrect dates for 302/337 (89.6%) records from this site. Miss-
ing data on gestational age affected trimester analysis for 381/940 (40.5%) women. However, we had 
valid data for at least 90% of all B4M diagnostic results and referral decisions- the core components of 
the intervention. Poor feedback on referrals and fragmented recordkeeping at health facilities made it 
challenging to ascertain how many women had eventually been referred and had complied with B4M re-
ferral. With the exception of identifying women in high-risk age groups, other socio-demographic data 
were not collected and device compliance at an individual level was not assessed. Although these nar-
rowed the extent to which the database could be further interrogated to identify factors explaining het-
erogeneous usage and for whom the device was most beneficial, facility level analysis was possible. While 
the economic implications of maintaining devices like B4M in low-resource settings is crucial to inform 
its sustainability, we were unable to present conclusive figures on costing and cost-effectiveness of the 
device. Finally, the nature and scope of the B4M intervention as a short-term proof of concept in seven 
health facilities limits transferability of findings to similar contexts within the Ghanaian health system. 
Nevertheless, findings are relevant for improving the device prototype and we conducted a district lev-
el stakeholders (health workers and district administrators) meeting at project end to discuss findings. 
These are necessary for further implementation research that can provide evidence on the possibility of 
bringing such an innovation to scale.
CONCLUSIONS
The B4M pilot suggests that similar interventions may help decrease unnecessary diagnostic referrals for 
women in rural settings and support continuity of care especially at primary level. Interactions between 
implementation strategies, technical features, behavioural dispositions, and context influenced usage be-
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